Ustekinumab for Refractory Colitis Associated with Immune Checkpoint Inhibitors. Thomas AS, Ma W, Wang Y. N Engl J Med 2021;384:581-583.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Thomas AS, Ma W, Wang Y. Ustekinumab for Refractory Colitis Associated with Immune Checkpoint Inhibitors. N Engl J Med 2021;384:581-583.
PMID: 33567198